Table 1. Cases of electromagnetic navigational bronchoscopic localization with indocyanine green and lipiodol—our experiences.
No | Sex | Age (years) | Diagnosis | Lobe | Size (mm) | Depth (mm) | Procedure time (min) | Operation | Operation time (min) |
---|---|---|---|---|---|---|---|---|---|
1 | Female | 33 | Benign | LLL | 12 | 12 | 20 | Segmentectomy | 50 |
2 | Female | 68 | Lung cancer | RLL | 15 | 34 | 21 | Segmentectomy | 222 |
3 | Female | 57 | Lung cancer | LLL | 16 | 5 | 25 | Segmentectomy | 195 |
4 | Male | 69 | Lung cancer | LLL | 9.1 | 10 | 19 | Segmentectomy | 165 |
5 | Male | 73 | Lung cancer | LLL | 12 | 0 | 16 | Segmentectomy | 133 |
6 | Male | 60 | Lung cancer | RUL | 13 | 15 | 15 | Lobectomy | 160 |
7 | Female | 53 | Lung cancer | LUL, LLL | Diffuse GGO | 0 | 24 | Wedge resection | 40 |
8 | Male | 59 | Metastatic cancer | RML, LUL | 10 | 10 | 17 | Wedge resection →RML lobectomy | 72 |
9 | Female | 62 | Lung cancer | RLL | 12 | 5 | 7 | Segmentectomy | 150 |
10 | Male | 67 | Lung cancer | RML | 5 | 5 | 18 | Wedge resection | 130 |
LLL, left lower lobe; RLL, right lower lobe; RUL, right upper lobe; RML, right middle lobe; LUL, left upper lobe; GGO, ground glass opacity.